| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 183.99B | 196.52B | 185.19B | 153.47B | 162.74B | 148.40B |
| Gross Profit | 40.40B | 42.31B | 40.59B | 31.71B | 33.12B | 29.93B |
| EBITDA | 19.26B | 20.73B | 21.34B | 10.44B | 15.04B | 12.83B |
| Net Income | 7.04B | 8.21B | 8.18B | 4.58B | 6.21B | 4.69B |
Balance Sheet | ||||||
| Total Assets | 389.00B | 372.51B | 337.45B | 341.67B | 223.47B | 204.31B |
| Cash, Cash Equivalents and Short-Term Investments | 47.12B | 48.04B | 42.74B | 47.87B | 33.43B | 39.17B |
| Total Debt | 256.08B | 227.00B | 210.46B | 227.38B | 127.97B | 118.57B |
| Total Liabilities | 303.14B | 283.40B | 265.78B | 276.53B | 163.87B | 149.69B |
| Stockholders Equity | 79.93B | 83.28B | 65.99B | 61.60B | 59.31B | 54.39B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -13.13B | 9.29B | -20.26B | -2.50B | 465.00M |
| Operating Cash Flow | 0.00 | 7.88B | 36.78B | -722.00M | 23.19B | 26.33B |
| Investing Cash Flow | 0.00 | -24.81B | -26.33B | -46.35B | -27.87B | -25.09B |
| Financing Cash Flow | 0.00 | 22.04B | -15.46B | 61.53B | -1.13B | 2.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥46.97B | 8.60 | ― | 3.01% | -1.93% | 47.35% | |
74 Outperform | ¥61.29B | 9.06 | ― | 6.02% | 1.33% | 9.59% | |
73 Outperform | ¥3.62T | 11.15 | 11.39% | 2.93% | 1.93% | 5.42% | |
73 Outperform | ¥6.46B | 12.93 | 3.32% | 4.53% | -15.55% | -41.48% | |
69 Neutral | ¥112.91B | 21.51 | 4.48% | 3.30% | -2.12% | 0.89% | |
68 Neutral | ¥57.00B | 6.17 | 6.98% | 7.35% | -21.50% | -56.82% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% |